Description: Panelists discuss their research study into actuarial issues stemming from care and disease management programs. Topics include programs, interventions, and measuring outcomes. From the Record of the Society of Actuaries, Vol. 31, No. 2, Session 31

Description: Panel discussion about ways can insurance carriers and health care coalitions work together, what data are coalitions requesting from health carriers, how health carriers respond to those requests, and implications for health carriers.

Description: Presented at May 2000 Spring Meeting. Discusses trends affecting costs for prescriptions, factors behind these trends, and cost management strategies for both the commercial and Medicare markets.

Description: Actuaries are increasingly being called upon to advise management about the value of medical management programs and interventions. This session discusses disease management outcome measurements and the cost vs value issues. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 111

Description: This panel discussion session examines the marketing and pricing considerations of group insurance in the 1980's.

Description: In this session, panelists discuss risk-based approach to solvency regulation, developments in the health RBC formula, differences between the health and life RBC formulas and strategies for improving one's health RBC position. From the Record of the Society of Actuaries, Volume 28, No. 2, Session 40

Description: This session is about health risk adjustments. Health care reform issues and Society of Actuaries research activities will also be discussed. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: Panelists with close ties to prescription drug programs provide information such as factors driving pharmacy cost increases, combating rising utilization, and the value of mail-order drug programs. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 53

Description: This is a highly interactive role-playing session detailing the actual product development process for a hypothetical health care product. From Record of Society of Actuaries, Vol. 30, No. 3, Session 19

Description: From a session at the Health/Pension Spring Meeting held in New Orleans, Louisiana June 15-17, 2005 Panelists discussed some of the research behind understanding decision-making and how this type of research can be used to enhance the modeling of consumer choice. Discussion of the field of behavioral economics and its potential application in improving assumptions for modeling health care purchasing.